Does EFAVIRENZ Cause Neoplasm progression? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Neoplasm progression have been filed in association with EFAVIRENZ (Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate). This represents 0.1% of all adverse event reports for EFAVIRENZ.
9
Reports of Neoplasm progression with EFAVIRENZ
0.1%
of all EFAVIRENZ reports
0
Deaths
6
Hospitalizations
How Dangerous Is Neoplasm progression From EFAVIRENZ?
Of the 9 reports, 6 (66.7%) required hospitalization.
Is Neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EFAVIRENZ. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does EFAVIRENZ Cause?
Virologic failure (916)
Foetal exposure during pregnancy (701)
Drug resistance (654)
Drug interaction (645)
Viral mutation identified (641)
Depression (602)
Pathogen resistance (567)
Maternal exposure during pregnancy (478)
Treatment failure (390)
Immune reconstitution inflammatory syndrome (301)
What Other Drugs Cause Neoplasm progression?
PALBOCICLIB (10,885)
SUNITINIB MALATE (1,920)
CYCLOPHOSPHAMIDE (1,588)
CARBOPLATIN (1,370)
AXITINIB (1,315)
DOXORUBICIN (1,276)
LETROZOLE (1,225)
PACLITAXEL (1,180)
CRIZOTINIB (1,161)
VINCRISTINE (1,106)
Which EFAVIRENZ Alternatives Have Lower Neoplasm progression Risk?
EFAVIRENZ vs EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL
EFAVIRENZ vs EFAVIRENZ\LAMIVUDINE\TENOFOVIR DISOPROXIL
EFAVIRENZ vs EFFEXOR
EFAVIRENZ vs EFFIENT
EFAVIRENZ vs EFGARTIGIMOD ALFA